Dr. Jonathan Brody is an Associate Professor in the Department of Surgery at the Thomas Jefferson University in Center City Philadelphia. He is currently the Director of Surgical Research and co-director of the Jefferson Pancreatic, Biliary, and Related Cancer Center. He is also a member of the Kimmel Cancer Center. Dr. Brody received his Ph.D. from The Johns Hopkins University School of Medicine, and his thesis specialized in studying the molecular aspects of cancer. During his training, Dr. Brody won the prestigious Experimental Pathologist-in-Training Award (EPIT) from the American Society of Investigative Pathology. He began to focus on pancreatic cancer in his post-doctoral training in the department of oncology at The Johns Hopkins University. In between, his pivotal studies on one of the common chemotherapeutic agent, 5-fluorouracil; he developed and patented a novel buffer for DNA identification (DNA electrophoresis buffer, co-owner of Faster Better Media, LLC). He was recently elected Chair of the Cancer Research Program (PRCRP), Department of Defense council and serves on many international study sections including the Tumor Biology and Genomics study section for the American Cancer Society. He also reviews articles for a number of top tier journals and is an acting Academic Editor for the PLoS ONE journal. He has published nearly 80 peer review publications in many top tier scientific and cancer journals including Nature Medicine, Journal of Biological Chemistry, and Cancer Research and has co-authored multiple book chapters and review articles on cancer. Additionally, he currently is an American Cancer Society Research Scholar and won the American Association of Cancer Research, Pancreatic Cancer Career Development Award.